May 8 |
Quanterix Corporation (QTRX) Q1 2024 Earnings Call Transcript
|
May 7 |
Quanterix Corporation (QTRX) Reports Q1 Loss, Tops Revenue Estimates
|
May 7 |
Quanterix GAAP EPS of -$0.26 beats by $0.05, revenue of $32.1M beats by $0.6M
|
May 7 |
Quanterix Releases Financial Results for the First Quarter of 2024
|
May 6 |
Quanterix Q1 Earnings Preview
|
Apr 29 |
Quanterix To Report First Quarter 2024 Financial Results
|
Apr 1 |
Investing in Quanterix (NASDAQ:QTRX) a year ago would have delivered you a 111% gain
|
Mar 21 |
Quanterix Outlines Partner Path With Labs to Expedite Building Global Alzheimer’s Disease Testing Infrastructure
|
Mar 6 |
Quanterix (QTRX) AD Offering Gets FDA's Breakthrough Device Tag
|
Mar 4 |
Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based p-Tau 217 Test for Alzheimer’s Disease
|